Somaticode was started to help individuals with the foundation of genetic health. One of those crucial foundations is 1-carbon metabolism. 1C metabolism is the system that is responsible for reading DNA (epigenetic expression), repairing DNA, neurotransmitter production (such as serotonin and dopamine), detoxification from damaged cells and free radicals/toxins, and much more. Because of it's central and foundational role in health, that's what we decided to focus on first. That focus lead to the creation of the Methyl Scale™, which quantifies both the genetic predisposition, commonly called the "methylation level" when based on a person's DNA, and the real-time measurement of methyl groups, or the Methyl Supply, in that person's body at any given time. With both of these in hand, we were able to help people adjust their daily health and mood, and help them focus on day-to-day changes that had long-term health benefits.
In 2023 we started offering our own DNA analysis. We wanted something that could capture more about health than Ancestry, 23andMe, and other leading providers could, since their focus is mainly on ancestry. And we achieved it. Starting with a wide-capture of your genetic code eliminates guesswork. This code, revealing potential predispositions, serves as a robust blueprint for enhancing health. The value of current DNA tests is debatable; while they sometimes offer insights, the challenge lies in identifying specific areas for improvement. Many reports highlight a plethora of potential issues, creating a bleak outlook. Furthermore, addressing potential future illnesses is less relevant for those struggling with daily overwhelm or anger. Consequently, we added a main focus to our "daily health" goal: enhancing mood and mental clarity to foster daily, healthy decision-making. This addition not only improves daily wellbeing but also establishes a consistent foundation for health.
Approach
Somaticode approaches health and mood from three directions: genetic predisposition, real-time methyl supply measurement, and real-time adjustments through diet, supplements, and activity.
Partnerships
We also support health care and wellness providers so that they can address the root cause of affective dysregulation in real time and provide ongoing treatment alongside their wellness regimens and specialized practice.
The Methyl Scale™ is the revolutionary centerpiece to Somaticode's platform. We use a powerful combination of whole-system methylation (1-carbon metabolism) and neurotransmitters to determine a score for each stage of biological maturity—3 stages for males, 4 for females. These numbers reveal the individual's predisposition to certain methyl supply level, and consequently affective and physiological symptoms, which is based on how much methyl their body is predisposed to produce. But unlike single-gene tests (e.g. MTHFR), this scale takes 15 major genetic and biologically systemic factors for the score alone. Add onto that the threats to methylation and neurotransmitters, and the impact of an individual's daily diet and activity, and it becomes clear why single-gene tests aren't enough to manage health and mood.
Methyl Scale™ numbers (methyl supply levels) change at each stage of biological maturity:
On this scale, -8.0 (undermethylation, depleted) is when an individual is not producing enough methyl for their mind and body to function properly, resulting in a range of symptoms. At the top end of the scale, +8.0 (overmethylation, overloaded) is when an individual is producing too much methyl, and comes with it's own set of symptoms. The ideal position, after treatment and a period of healing has taken place, is closer to 0 (methyl-balanced).
Somaticode's approach focuses on discovering, regulating, and protecting patients' Methyl Scale™ numbers and neurotransmitters through non-pharmacological means. Health care and wellness providers use the scale to address emotional, mental, physical, and mood-related turmoil their patients face.
Founded by Dr. James Bradshaw in 2016, a Developmental and Cell Biology expert, Somaticode is a precision health technology company that provides methylation balancing and genetic dieting guidance to help individuals optimize their overall health and well-being. Drawing from his extensive experience in genetics, anatomy, physiology, and embryology, Dr. Bradshaw has developed a unique, whole-system approach to health, focusing on the body's functions and methylation rather than just a few genes. This led to the development of the Methyl Scale™, which gives individuals a better sense of their body's methylation level from one day to the next. The idea for Somaticode stems from Dr. Bradshaw's personal journey and his success in using this approach within his own family. Today, Somaticode continues to empower individuals to take control of their health and live according to what's best for their genes.
By reducing the biological noise that distracts, disrupts, and unbalances our minds, we can focus on building better habits, making better lifestyle and diet choices, or accomplishing whatever has been put off for far too long. That's the purpose of Somaticode: to enable people to think and feel clearer so that they can consistently make more level-headed decisions, especially about their health.